Q1 2025 Earnings Conference Call April 22, 2025 8:00 AM ETCompany ParticipantsJohn Bedford - VP, IRRainer Blair - ...

In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives.

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

The most recent trading session ended with Moderna (MRNA) standing at $24.73, reflecting a -1.85% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500's ...

This shift is expected to bolster the company’s position in the genetic medicines market, particularly for mRNA/DNA products and cell and gene therapies. The company’s strategic moves come at ...

One researchers explained that bacteria do a really, really good job of keeping the sequence you want and the sequence that you get.

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an earnings perspective. As one of the leading coronavirus vaccine companies ...

TULSA, Okla. — The Tulsa Police Department is gearing up to start using the state's first ever M-VAC DNA testing machine. The M-Vac Systems Company showcased its advanced machine on April 16 ...

Officers said recent DNA advancements led to the identification of Jerald Leroy McAdams as the primary suspect in two kidnapping and rape cases that took place in 1994 and 1997 in Ogden.

mRNA vaccines achieved their first success against COVID-19, but could a bigger target be next? Ben Hargreaves examines whether the technology could provide a new tool against cancer, and how ...